We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Recipient Race as a Risk Factor in Renal Transplantation

Paul J. Garvin, MD; Marco Castaneda, MD; John E. Codd, MD; Keith Mauller, PAC
Arch Surg. 1983;118(12):1441-1444. doi:10.1001/archsurg.1983.01390120061016.
Text Size: A A A
Published online


• We analyzed 118 renal transplants performed from November 1977 through October 1981 to determine the effect of recipient race on graft and patient survival. Fifty-one cadaver and three living related transplants were performed in the black recipients and 41 cadaver and 23 living related transplants in the white recipients. No significant differences existed between the groups in regard to age, incidence of pretransplant nephrectomy or splenectomy, warm ischemia time, perfusion time, panel-reactive alloantibody (PRA) status, or number of pretransplant blood transfusions. The mean HLA-A and -B locus match was significantly less in black cadaver recipients and the incidence of malignant hypertension was significantly greater in black recipients. The one-year graft survival rate was 54.9% for black cadaver recipients and 48.7% for white cadaver recipients with a corresponding patient survival rate of 86.2% and 85.3%. The one-year graft survival rate for living-related recipients was 100% for blacks and 73.9% for whites with a corresponding patient survival rate of 100% and 86.9%. These results were not significantly different. When the recipients were matched for age, pretransplant transfusions, HLA-A and -B locus matching, and PRA status, no difference in transplant outcome was identified. We concluded that recipient race is not of prognostic significance in determining the outcome of either cadaver or living related donor transplantation.

(Arch Surg 1983;118:1441-1444)


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.